New Technologies Reduce Variability in Breast Cancer SubtypingBrydie Thomas-Moore, PhD | March 1, 2021 Emerging technologies in breast cancer diagnostics aim to improve the accuracy of breast cancer subtyping
SponsoredFour Keys to Successful Vaccine StorageClinical Lab Manager | February 8, 2021 Reliable storage and temperature monitoring are essential to maintain the cold chain and avoid catastrophic vaccine loss
Biobanking Informatics: The Key to StandardizationJustin G. Mychek-Londer, PhD | January 29, 2021 As the use of biobanks increases in clinical settings, more informatics tools are coming available to ensure the quality of biospecimens and data
Applications & ProductsSponsoredOptimize COVID-19 Sample Accessioning and Processing WorkflowsClinical Lab Manager | January 27, 2021 Discover what labs have learned since the beginning of the pandemic to optimize your lab's COVID-19 workflows
Strategies to Enhance the Quality of Automated Drug Screening SystemsBrydie Thomas-Moore, PhD | January 12, 2021 With throughput no longer the major limiting factor in drug screening, focus now lies on how to improve quality
SponsoredSolutions to Expanded Carrier Screening for Highly Homologous GenesClinical Lab Manager | December 2, 2020 NGS and sophisticated bioinformatics algorithms are improving the accuracy with which the homologous genes, such as SMN1 and SMN2, involved in inherited disorders can be mapped
A Timeline of the CRISPR/Cas SystemMichelle Dotzert, PhD | November 11, 2020 From discovery and development to clinical applications
Utility of Electronic Health Records in Randomized Controlled TrialsMichelle Dotzert, PhD | November 1, 2020 Beyond interventions, EHRS may be used for recruitment and outcome assessment
POCT for Blood Donation: What are the Risks and Benefits?Oreoluwa Ogunyemi, MD | September 4, 2020 Convenience must be balanced with a level of accuracy and reliability that ensures donations do not harm volunteers or patients
NGS versus Sanger Sequencing for Clinical DecisionsRahul Sharma, PhD | July 7, 2020 It would be an unnecessary stretch of resources in the clinical setting to use NGS for needs that can be satisfied by Sanger sequencing
Pathogen Proteotyping: A Game Changer for Clinical MicrobiologyRaeesa Gupte, PhD | July 6, 2020 How mass spectrometry can transform the diagnosis and treatment of infectious diseases
Influenza Diagnostic Methods: RT-PCR vs. RIDTsSuzanne Leech, PhD | May 1, 2020 RT-PCR is considered the gold standard, but certain situations may call for the use of RIDTs
Molecular Tools for Tuberculosis TestingRaeesa Gupte, PhD | May 1, 2020 Novel diagnostic approaches for accurate, comprehensive, and accelerated results
Flow Cytometry Reveals Immune System Dysregulation in Coronavirus PatientsMiriam Bergeret, MSc | April 22, 2020 How multiparameter flow cytometry can give a rapid picture of a patient’s immune response from a single blood sample
NGS in Routine Cancer TestingGeorgia McDonald, BSc, MSc, MPhil, PhD | March 13, 2020 Current efforts and obstacles for use of next-generation sequencing in routine oncology practice
Multiplexed Immunohistochemistry: Maximizing the Use of Tissue SectionsRaeesa Gupte, PhD | February 23, 2020 A technique at the intersection of high throughput and high resolution
How to Implement Automation in the LabErica Tennenhouse, PhD | February 13, 2020 Laboratory leaders should know their customers, their workflow, and their goals before beginning to automate
Trends in Point-Of-Care TestingNeeta Ratanghayra, M.Pharm | November 30, 2019 Point-of-care technologies hold tremendous potential to improve health care delivery
Detecting Rare Cell Events: Flow Cytometry Versus MicroscopyRaeesa Gupte, PhD | November 30, 2019 Technical solutions to the unique challenges of rare cell detection
Biobanking: Current State and Future ProspectsJulia Jenkins, PhD | November 30, 2019 The future of biobanking is intimately tied to the new and rapidly expanding era of personalized medicine